Skip to main content
. 2020 Sep 25;11(9):802. doi: 10.1038/s41419-020-03003-w

Fig. 6. Modulation of CD36 expression in the liver directly affects NAFLD.

Fig. 6

CD36 not only acts as a FFA transporter but also regulates β-oxidation and autophagy among others lipid metabolism pathways in liver cells. Overexpression of hepatic CD36 concurs with a marked elevation of hepatic FFAs uptake and decreased β-oxidation and autophagy, thus contributing to hepatosteatosis. Conversely, downregulation of hepatic CD36 diminishes FFAs uptake and increases β-oxidation and autophagy protecting against hepatosteatosis.